Insulet downgraded at Oppenheimer on growing risks
· seekingalpha.com
Oppenheimer downgrades Insulet on softer growth outlook and type 2 diabetes concerns. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...